Dendritic cell based tumor vaccination in prostate and renal cell cancer: a systematic review and meta-analysis

Oncolytic virus-initiated protective immunity against prostate cancer

KNK437, a benzylidene lactam compound, sensitises prostate cancer cells to the apoptotic effect of hyperthermia

Sipuleucel-T: in metastatic castration-resistant prostate cancer

Dendritic cell-based immunotherapy for prostate cancer

RIG-I helicase-independent pathway in sendai virus-activated dendritic cells is critical for preventing lung metastasis of AT6.3 prostate cancer

Hyperthermia combined with radiation for the treatment of locally advanced prostate cancer: long-term results from Dana-Farber Cancer Institute study 94-153

Measurement and mathematical modeling of thermally induced injury and heat shock protein expression kinetics in normal and cancerous prostate cells

Harnessing naturally occurring tumor immunity: a clinical vaccine trial in prostate cancer

[Auto-dendritic cell vaccines pulsed with PSA, PSMA and PAP peptides for hormone-refractory prostate cancer]